Display options
Cite
Milner E, Johnson AW, Nelson JW, et al. HIF-1α Mediates Isoflurane-Induced Vascular Protection in Subarachnoid Hemorrhage. Ann Clin Transl Neurol. 2015;2(4):325-37doi: 10.1002/acn3.170.
Milner, E., Johnson, A. W., Nelson, J. W., Harries, M. D., Gidday, J. M., Han, B. H., & Zipfel, G. J. (2015). HIF-1α Mediates Isoflurane-Induced Vascular Protection in Subarachnoid Hemorrhage. Annals of clinical and translational neurology, 2(4), 325-37. https://doi.org/10.1002/acn3.170
Milner, Eric, et al. "HIF-1α Mediates Isoflurane-Induced Vascular Protection in Subarachnoid Hemorrhage." Annals of clinical and translational neurology vol. 2,4 (2015): 325-37. doi: https://doi.org/10.1002/acn3.170
Milner E, Johnson AW, Nelson JW, Harries MD, Gidday JM, Han BH, Zipfel GJ. HIF-1α Mediates Isoflurane-Induced Vascular Protection in Subarachnoid Hemorrhage. Ann Clin Transl Neurol. 2015 Apr;2(4):325-37. doi: 10.1002/acn3.170. Epub 2015 Feb 21. PMID: 25909079; PMCID: PMC4402079.
Copy Download .nbib Format: NLM
Share it on

Ann Clin Transl Neurol. 2015 Apr;2(4):325-37. doi: 10.1002/acn3.170. Epub 2015 Feb 21.

HIF-1α Mediates Isoflurane-Induced Vascular Protection in Subarachnoid Hemorrhage.

Annals of clinical and translational neurology

Eric Milner, Andrew W Johnson, James W Nelson, Michael D Harries, Jeffrey M Gidday, Byung Hee Han, Gregory J Zipfel

Affiliations

  1. Department of Neurological Surgery, Washington University School of Medicine St. Louis, Missouri, 63108 ; Program in Neuroscience, Washington University School of Medicine St. Louis, Missouri, 63108.
  2. Department of Neurological Surgery, Washington University School of Medicine St. Louis, Missouri, 63108.
  3. Department of Neurological Surgery, Washington University School of Medicine St. Louis, Missouri, 63108 ; Hope Center for Neurological Disorders, Washington University School of Medicine St. Louis, Missouri, 63108.
  4. Department of Neurological Surgery, Washington University School of Medicine St. Louis, Missouri, 63108 ; Hope Center for Neurological Disorders, Washington University School of Medicine St. Louis, Missouri, 63108 ; Department of Neurology, Washington University School of Medicine St. Louis, Missouri, 63108.

PMID: 25909079 PMCID: PMC4402079 DOI: 10.1002/acn3.170

Abstract

OBJECTIVE: Outcome after aneurysmal subarachnoid hemorrhage (SAH) depends critically on delayed cerebral ischemia (DCI) - a process driven primarily by vascular events including cerebral vasospasm, microvessel thrombosis, and microvascular dysfunction. This study sought to determine the impact of postconditioning - the phenomenon whereby endogenous protection against severe injury is enhanced by subsequent exposure to a mild stressor - on SAH-induced DCI.

METHODS: Adult male C57BL/6 mice were subjected to sham, SAH, or SAH plus isoflurane postconditioning. Neurological outcome was assessed daily via sensorimotor scoring. Contributors to DCI including cerebral vasospasm, microvessel thrombosis, and microvascular dysfunction were measured 3 days later. Isoflurane-induced changes in hypoxia-inducible factor 1alpha (HIF-1α)-dependent genes were assessed via quantitative polymerase chain reaction. HIF-1α was inhibited pharmacologically via 2-methoxyestradiol (2ME2) or genetically via endothelial cell HIF-1α-null mice (EC-HIF-1α-null). All experiments were performed in a randomized and blinded fashion.

RESULTS: Isoflurane postconditioning initiated at clinically relevant time points after SAH significantly reduced cerebral vasospasm, microvessel thrombosis, microvascular dysfunction, and neurological deficits in wild-type (WT) mice. Isoflurane modulated HIF-1α-dependent genes - changes that were abolished in 2ME2-treated WT mice and EC-HIF-1α-null mice. Isoflurane-induced DCI protection was attenuated in 2ME2-treated WT mice and EC-HIF-1α-null mice.

INTERPRETATION: Isoflurane postconditioning provides strong HIF-1α-mediated macro- and microvascular protection in SAH, leading to improved neurological outcome. These results implicate cerebral vessels as a key target for the brain protection afforded by isoflurane postconditioning, and HIF-1α as a critical mediator of this vascular protection. They also identify isoflurane postconditioning as a promising novel therapeutic for SAH.

References

  1. Stroke. 2004 Nov;35(11 Suppl 1):2687-9 - PubMed
  2. Kidney Int. 1997 Feb;51(2):553-5 - PubMed
  3. Cancer Cell. 2003 Apr;3(4):363-75 - PubMed
  4. Neurol Res. 2008 Apr;30(3):268-71 - PubMed
  5. Neurosurgery. 2014 Apr;74(4):351-8; discussion 358-9 - PubMed
  6. Neuroscience. 2013 Nov 12;252:420-30 - PubMed
  7. Int J Biochem Cell Biol. 2005 Mar;37(3):535-40 - PubMed
  8. J Neurosci. 2008 Dec 10;28(50):13542-50 - PubMed
  9. J Ethnopharmacol. 2014 Jun 11;154(2):443-52 - PubMed
  10. Brain Res. 2012 Apr 27;1451:1-9 - PubMed
  11. Stroke. 2003 Feb;34(2):338-41 - PubMed
  12. FASEB J. 2013 Jan;27(1):187-98 - PubMed
  13. Stroke. 2004 Aug;35(8):1862-6 - PubMed
  14. Sci Signal. 2010 Mar 02;3(111):ra15 - PubMed
  15. Brain Res. 2008 Dec 15;1245:26-35 - PubMed
  16. J Appl Physiol (1985). 2008 Apr;104(4):1185-91 - PubMed
  17. Stroke. 2005 Jun;36(6):1264-9 - PubMed
  18. Neurosurgery. 1998 May;42(5):979-86; discussion 986-7 - PubMed
  19. Anesth Analg. 2010 May 1;110(5):1412-8 - PubMed
  20. Exp Neurol. 2006 Dec;202(2):348-56 - PubMed
  21. Crit Care Med. 2012 Jun;40(6):1908-13 - PubMed
  22. Stroke Res Treat. 2013;2013:948783 - PubMed
  23. Anesth Analg. 2001 Apr;92(4):990-6 - PubMed
  24. Acta Neurochir Suppl. 2011;111:141-4 - PubMed
  25. Mol Pharmacol. 2004 May;65(5):1172-80 - PubMed
  26. Psychiatry Clin Neurosci. 2008 Dec;62(6):705-12 - PubMed
  27. Anesth Analg. 2011 Aug;113(2):343-8 - PubMed
  28. J Cereb Blood Flow Metab. 2007 Jul;27(7):1377-86 - PubMed
  29. J Neurochem. 2012 Dec;123(6):954-62 - PubMed
  30. Nat Neurosci. 2011 Oct 26;14(11):1363-8 - PubMed
  31. Nat Rev Neurol. 2014 Jan;10(1):44-58 - PubMed
  32. J Neurosci. 2006 Sep 13;26(37):9471-81 - PubMed
  33. Stroke. 2002 Jul;33(7):1889-98 - PubMed
  34. Acta Neurochir Suppl. 2008;104:139-47 - PubMed
  35. Asian Pac J Trop Med. 2013 Oct;6(10):762-7 - PubMed
  36. Stroke. 2012 Sep;43(9):2513-6 - PubMed
  37. Stroke. 2010 Oct;41(10 ):2391-5 - PubMed
  38. Eur J Anaesthesiol. 2009 Mar;26(3):201-6 - PubMed
  39. Anesth Analg. 2007 May;104(5):1066-77, tables of contents - PubMed
  40. Brain Res. 2013 Jun 23;1517:114-21 - PubMed
  41. J Cereb Blood Flow Metab. 2011 Jan;31(1):132-43 - PubMed
  42. Brain Res. 2012 Apr 4;1447:1-8 - PubMed
  43. Mol Vis. 2013 Nov 23;19:2360-72 - PubMed
  44. Curr Opin Pharmacol. 2008 Feb;8(1):104-10 - PubMed
  45. Neurosurgery. 2008 Jan;62(1):232-40; discussion 240-1 - PubMed
  46. J Mol Neurosci. 2012 Sep;48(1):273-80 - PubMed
  47. Neuroscience. 2011 Dec 29;199:44-50 - PubMed
  48. Stroke. 2009 Jun;40(6):2244-50 - PubMed
  49. Stroke. 2010 Jul;41(7):1521-7 - PubMed
  50. Stroke. 2011 Mar;42(3):776-82 - PubMed
  51. Stroke. 2011 Mar;42(3):754-63 - PubMed
  52. Anesth Analg. 2003 Jan;96(1):233-7, table of contents - PubMed
  53. Anesthesiology. 2004 Sep;101(3):695-703 - PubMed
  54. Exp Neurol. 2005 Oct;195(2):407-15 - PubMed
  55. Cell Mol Neurobiol. 2012 May;32(4):491-507 - PubMed
  56. J Cereb Blood Flow Metab. 2005 Aug;25(8):939-48 - PubMed
  57. Stroke. 2007 Apr;38(4):1329-35 - PubMed
  58. Neurology. 1986 Mar;36(3):329-33 - PubMed
  59. Neurobiol Dis. 2000 Feb;7(1):38-53 - PubMed
  60. Cancer Cell. 2004 Nov;6(5):485-95 - PubMed
  61. J Cereb Blood Flow Metab. 2013 Jul;33(7):1008-14 - PubMed

Publication Types

Grant support